1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech)" is currently closed and not accepting applications.
Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech) is sponsored by National Science Foundation (NSF), National Institutes of Health (NIH), and Food and Drug Administration (FDA).
This program supports interdisciplinary research projects focusing on the mathematical and engineering foundations for developing and using digital twins and synthetic data in biomedical and healthcare applications, especially for evaluating medical devices and addressing challenges in biomedical technologies.
The goal is to catalyze biomedical technological innovation through new foundational methods and algorithms relevant to digital twins and synthetic humans, incorporating AI capabilities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech) | NSF - U.S. National Science Foundation Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech) Important information for proposers and award recipients All proposals must be submitted in accordance with the requirements specified in the funding opportunity and in the Proposal & Award Policies & Procedures Guide (PAPPG) and its supplements .
All NSF grants and cooperative agreements are subject to the applicable set of NSF award terms and conditions . NSF has updated its research security policies for NSF funded projects. Supports interdisciplinary research projects that explore the mathematical and engineering foundations behind the development and use of digital twins in biomedical and healthcare applications.
Supports interdisciplinary research projects that explore the mathematical and engineering foundations behind the development and use of digital twins in biomedical and healthcare applications.
The Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech) program supports inherently interdisciplinary research projects that underpin the mathematical and engineering foundations behind the development and use of digital twins and synthetic data in biomedical and healthcare applications, with a particular focus on digital, in silico models used in the evaluation of medical devices and the relevance of the developed models in addressing current and emerging challenges affecting the development and assessment of biomedical technologies.
The goal of the FDT-BioTech initiative is to catalyze biomedical technological innovation through new foundational development of methods and algorithms relevant to digital twins and synthetic humans.
May 15, 2024 - DMS Virtual Office Hour April 22, 2024 - FDT-BioTech webinar Awards made through this program Browse projects funded by this program Map of recent awards made through this program Directorate for Mathematical and Physical Sciences (MPS) Division of Mathematical Sciences (MPS/DMS) Directorate for Computer and Information Science and Engineering (CISE) Office of Advanced Cyberinfrastructure (CISE/OAC)
According to the current listing, eligibility includes: Supports interdisciplinary research projects that underpin the mathematical and engineering foundations behind the development and use of digital twins in biomedical and healthcare applications. Universities are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows $4,000,000 to $5,000,000 in FY24 (up to 3 years); collaborative projects up to $1,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 3, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech) is funded by National Science Foundation (NSF), National Institutes of Health (NIH), and Food and Drug Administration (FDA). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
MGPV Travel Grant is sponsored by Geological Society of America (GSA), Mineralogy, Geochemistry, Petrology, Volcanology Division. MGPV Travel grants support student travel to the annual GSA meeting. Applications are restricted to active graduate or undergraduate students who are the presenting authors of an accepted abstract at the annual GSA meeting.
Research Opportunities in Space and Earth Science (ROSES) - 2025: A.4 Rapid Response and Novel Research in Earth Science is sponsored by National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD). This omnibus research funding opportunity includes various program elements, with rolling submissions for Earth Science research through August 2026. Proposers to Earth Science using the NASA Center for Climate Simulation high-end computing facility must include specific budget details.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleNew NIH awards have fallen 34% in 2026, NSF is running months behind, and a proposed OMB rule would let political appointees terminate grants mid-stream. The funding environment for academic research has structurally changed. Here is a clear-eyed diversification strategy for PIs, research offices, and institutions that cannot wait for the political fight to resolve.
Read articleOMB's proposed rewrite of 2 CFR Part 200 would bar political appointees from deferring to peer reviewers and require senior-appointee sign-off on every discretionary grant. NIH new awards are already down about 34% in 2026. Here is what the merit-review changes actually say, how 'Gold Standard Science' becomes a scoring lever, why R1 universities are being written out of some solicitations, and what principal investigators and research offices should do before October 1.
Read article